PDCD1 and diffuse large B-cell lymphoma: Pretreating OVA-loaded IμHABcl6-FRCs with blocking antibodies against PD-1 ligands significantly increased the subsequent cytotoxic function of OT-I T cells against OVA-DLBCL cells, whereas the treatment of WT-FRCs had no effect (Figure 8G).